John A. Ward

Array ( [id] => 6760742 [patent_doc_number] => 20030124103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Tumor cells with increased immunogenicity and uses therefor' [patent_app_type] => new [patent_app_number] => 10/261101 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14903 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124103.pdf [firstpage_image] =>[orig_patent_app_number] => 10261101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835190 [patent_doc_number] => 20030162736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Medicament comprising NK4 gene or recombinant NK4 protein' [patent_app_type] => new [patent_app_number] => 10/255649 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15330 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162736.pdf [firstpage_image] =>[orig_patent_app_number] => 10255649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 760766 [patent_doc_number] => 07011974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Method for producing monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 10/244894 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4308 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/011/07011974.pdf [firstpage_image] =>[orig_patent_app_number] => 10244894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760741 [patent_doc_number] => 20030124102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Pax-encoding vector and use thereof' [patent_app_type] => new [patent_app_number] => 10/245171 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11811 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124102.pdf [firstpage_image] =>[orig_patent_app_number] => 10245171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760741 [patent_doc_number] => 20030124102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Pax-encoding vector and use thereof' [patent_app_type] => new [patent_app_number] => 10/245171 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11811 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124102.pdf [firstpage_image] =>[orig_patent_app_number] => 10245171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801246 [patent_doc_number] => 20060035809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Apoptosis-mimicking natural vesicles and use thereof in medical treatment' [patent_app_type] => utility [patent_app_number] => 10/489999 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3265 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035809.pdf [firstpage_image] =>[orig_patent_app_number] => 10489999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270211 [patent_doc_number] => 07563445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'CD40 binding molecules and CTL peptides for treating tumors' [patent_app_type] => utility [patent_app_number] => 10/227789 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 5385 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563445.pdf [firstpage_image] =>[orig_patent_app_number] => 10227789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658274 [patent_doc_number] => 20030133910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Wild-type ras as a cancer therapeutic agent' [patent_app_type] => new [patent_app_number] => 10/227596 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15923 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133910.pdf [firstpage_image] =>[orig_patent_app_number] => 10227596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6649354 [patent_doc_number] => 20030104626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy' [patent_app_type] => new [patent_app_number] => 10/219414 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16589 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104626.pdf [firstpage_image] =>[orig_patent_app_number] => 10219414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750978 [patent_doc_number] => 20030045499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses' [patent_app_type] => new [patent_app_number] => 10/216346 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27295 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045499.pdf [firstpage_image] =>[orig_patent_app_number] => 10216346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674839 [patent_doc_number] => 20030060442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'In situ injection of antigen-presenting cells with genetically enhanced cytokine expression' [patent_app_type] => new [patent_app_number] => 10/213939 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7499 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060442.pdf [firstpage_image] =>[orig_patent_app_number] => 10213939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258678 [patent_doc_number] => 20020187142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Bispecific molecules cross-linking ITIM and ITAM for therapy' [patent_app_type] => new [patent_app_number] => 10/213216 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4155 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187142.pdf [firstpage_image] =>[orig_patent_app_number] => 10213216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616644 [patent_doc_number] => 07145056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Production of antibodies using cre-mediated site-specific recombination' [patent_app_type] => utility [patent_app_number] => 10/210425 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12499 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/145/07145056.pdf [firstpage_image] =>[orig_patent_app_number] => 10210425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585506 [patent_doc_number] => 07446185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Her2/neu target antigen and use of same to stimulate an immune response' [patent_app_type] => utility [patent_app_number] => 10/484067 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15267 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446185.pdf [firstpage_image] =>[orig_patent_app_number] => 10484067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807314 [patent_doc_number] => 08444964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Compositions and methods for enhanced tumor cell immunity in vivo' [patent_app_type] => utility [patent_app_number] => 10/192952 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11977 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10192952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813687 [patent_doc_number] => 20030073237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Gene therapy to promote angiogenesis and/or the treatment of heart failure' [patent_app_type] => new [patent_app_number] => 10/189809 [patent_app_country] => US [patent_app_date] => 2002-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6598 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073237.pdf [firstpage_image] =>[orig_patent_app_number] => 10189809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 708297 [patent_doc_number] => 07060871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function' [patent_app_type] => utility [patent_app_number] => 10/183344 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 28 [patent_no_of_words] => 12824 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060871.pdf [firstpage_image] =>[orig_patent_app_number] => 10183344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429265 [patent_doc_number] => 20040001809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Methods and apparatus for enhancing a response to nucleic acid vaccines' [patent_app_type] => new [patent_app_number] => 10/184143 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6852 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001809.pdf [firstpage_image] =>[orig_patent_app_number] => 10184143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296241 [patent_doc_number] => 07541513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Mouse λ light chain locus' [patent_app_type] => utility [patent_app_number] => 10/481395 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5903 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541513.pdf [firstpage_image] =>[orig_patent_app_number] => 10481395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682795 [patent_doc_number] => 20030118659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Antigen-specific induction of peripheral immune tolerance' [patent_app_type] => new [patent_app_number] => 10/162652 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5067 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118659.pdf [firstpage_image] =>[orig_patent_app_number] => 10162652 [rel_patent_id] =>[rel_patent_doc_number] =>)